JUCTCi014-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	JUCTCi014-A
Cite as:	JUCTCi014-A (RRID:CVCL_A1PL)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	20th November 2025
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	the University of Jordan / Cell Therapy center (JUCTC) Contact: the University of Jordan / Cell Therapy center (JUCTC)
Owner	the University of Jordan / Cell Therapy center (JUCTC)
Distributors	the University of Jordan / Cell Therapy center (JUCTC)
External Databases
Cellosaurus	CVCL_A1PL
Wikidata	Q102114336
BioSamples	SAMEA118585747
General Information
Publications	Ababneh NA et al. Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton's jelly samples. Stem cell research. 2020 Dec;49:102000. Sundaravadivelu PK et al. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview. Advances in experimental medicine and biology. 2022;1376:151-180. Jafar Hanan et al. Adipose-derived mesenchymal stromal cell secretome protects against kidney injury through induction of heme oxygenase 1 upregulation in vitro. World Journal of Nephrology. 2025-09-25.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: allowed

hIPSC Derivation

General